Cytoki Pharma is a clinical-stage biotechnology company developing lipidated IL-22 therapeutics to treat metabolic diseases like obesity, type 2 diabetes, and inflammatory bowel disease (IBD)
Cytoki Pharma is a clinical-stage biotechnology company developing lipidated IL-22 therapeutics to treat metabolic diseases like obesity, type 2 diabetes, and inflammatory bowel disease (IBD).